clozapine and Lung-Diseases

clozapine has been researched along with Lung-Diseases* in 2 studies

Other Studies

2 other study(ies) available for clozapine and Lung-Diseases

ArticleYear
Probable clozapine-induced parenchymal lung disease and perimyocarditis: a case report.
    BMC psychiatry, 2016, 12-08, Volume: 16, Issue:1

    Clozapine is the archetypical atypical antipsychotic, its primary indication being treatment resistant schizophrenia. Severe side effects caused by clozapine, including leukopenia, agranulocytosis, and myocarditis, are well known. A rarely described side effect is concurrent perimyocarditis and parenchymal lung disease.. A previously physically healthy 23-year-old male Caucasian that suffered from schizophrenia presented with flu-like symptoms 1 week after starting clozapine treatment. Treatment with clozapine was discontinued. He developed respiratory distress. Investigations showed significant parenchymal infiltration in both of the lungs, pericardial fluid, and heart failure. He initially received treatment for suspected malignant neuroleptic syndrome and later for suspected infection, but these tentative diagnoses were not confirmed. The patient's condition gradually improved. In retrospect, clozapine-induced parenchymal lung disease and perimyocarditis were deemed the most probable causes.. Concurrent perimyocarditis and parenchymal lung disease are rare side effects of clozapine. Clozapine-induced disease in general is considered an exclusion diagnosis. Lacking a verifiable diagnosis when suspecting a side effect of clozapine, clinicians might treat the most likely and serious condition presenting and consider discontinuing clozapine until the diagnostic uncertainty is reasonably resolved.

    Topics: Adult; Antipsychotic Agents; Clozapine; Diagnosis, Differential; Humans; Lung Diseases; Male; Myocarditis; Pericarditis; Schizophrenia; Young Adult

2016
Spiking fevers with clozapine treatment.
    Clinical neuropharmacology, 1997, Volume: 20, Issue:2

    Clozapine often causes low-grade fever and less frequently spiking fever. We describe three cases of spiking fever that occurred in the first 3 weeks of clozapine therapy. A new set of side effects of clozapine is identified, which includes spiking fever, respiratory and gastrointestinal symptoms, and neutrophilia. Possible mechanisms are discussed.

    Topics: Adult; Antipsychotic Agents; Clozapine; Female; Fever; Gastrointestinal Diseases; Humans; Leukocyte Count; Lung Diseases; Male; Neutrophils; Psychotic Disorders; Schizophrenia, Paranoid

1997